TY - JOUR
T1 - Enfermedad Pulmonar Obstructiva Crónica (EPOC) y diferentes aspectos de su impacto social
T2 - Un documento multidisciplinar de opinión
AU - Bouza, Emilio
AU - Alvar, Agustí
AU - Almagro, Pere
AU - Alonso, Tamara
AU - Ancochea, Julio
AU - Barbé, Ferrán
AU - Corbella, Josep
AU - Gracia, Diego
AU - Mascarós, Enrique
AU - Melis, Joan
AU - Miravitlles, Marc
AU - Pastor, Mariano
AU - Pérez, Patricia
AU - Rudilla, David
AU - Torres, Antoni
AU - Soriano, Joan Bautista
AU - Vallano, Antoni
AU - Vargas, Franciso
AU - Palomo, Esteban
N1 - ©The Author 2020. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
PY - 2020/1/23
Y1 - 2020/1/23
N2 - Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases in the World, and one of the most important causes of mortality and morbidity. In adults 40 years and older, it affects more than 10% of the population and has enormous personal, family and social burden. Tobacco smoking is its main cause, but not the only one, and there is probably a genetic predisposition that increases the risk in some patients. The paradigm of this disease is changing in Spain, with an increase of women that has occurred in recent years. Many of the physiopathological mechanisms of this condition are well known, but the psychological alterations to which it leads, the impact of COPD on relatives and caregivers, the limitation of daily life observed in these patients, and the economic and societal burden that they represent for the health system, are not so well-known. A major problem is the high under-diagnosis, mainly due to difficulties for obtaining, in a systematic way, spirometries in hospitals and health-care centers. For this reason, the Fundación de Ciencias de la Salud and the Spanish National Network Center for Research in Respiratory Diseases (CIBERES) have brought together experts in COPD, patients and their organizations, clinical psychologists, experts in health economics, nurses and journalists to obtain their opinion about COPD in Spain. They also discussed the scientific bibliometrics on COPD that is being carried out from the CIBERES and speculated on the future of this condition. The format of the meeting consisted in the discussion of a series of questions that were addressed by different speakers and discussed until a consensus conclusion was reached.
AB - Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases in the World, and one of the most important causes of mortality and morbidity. In adults 40 years and older, it affects more than 10% of the population and has enormous personal, family and social burden. Tobacco smoking is its main cause, but not the only one, and there is probably a genetic predisposition that increases the risk in some patients. The paradigm of this disease is changing in Spain, with an increase of women that has occurred in recent years. Many of the physiopathological mechanisms of this condition are well known, but the psychological alterations to which it leads, the impact of COPD on relatives and caregivers, the limitation of daily life observed in these patients, and the economic and societal burden that they represent for the health system, are not so well-known. A major problem is the high under-diagnosis, mainly due to difficulties for obtaining, in a systematic way, spirometries in hospitals and health-care centers. For this reason, the Fundación de Ciencias de la Salud and the Spanish National Network Center for Research in Respiratory Diseases (CIBERES) have brought together experts in COPD, patients and their organizations, clinical psychologists, experts in health economics, nurses and journalists to obtain their opinion about COPD in Spain. They also discussed the scientific bibliometrics on COPD that is being carried out from the CIBERES and speculated on the future of this condition. The format of the meeting consisted in the discussion of a series of questions that were addressed by different speakers and discussed until a consensus conclusion was reached.
KW - Chronic Obstructive Pulmonary Disease
KW - COPD
KW - Health Economics
KW - Health-Care burden
KW - Patients organizations
KW - Psychological impact
KW - Research bibliometrics
KW - Spirometry
KW - Anxiety/etiology
KW - Bibliometrics
KW - Biomedical Research
KW - Communications Media
KW - Cost of Illness
KW - Depression/etiology
KW - Family
KW - Female
KW - Humans
KW - Male
KW - Nursing Care
KW - Patient Compliance
KW - Patient Participation
KW - Prevalence
KW - Pulmonary Disease, Chronic Obstructive/diagnosis
KW - Pulmonary Medicine/education
KW - Quality-Adjusted Life Years
KW - Sex Factors
KW - Sick Leave/economics
KW - Smoking Cessation
KW - Smoking/adverse effects
KW - Spain/epidemiology
KW - Spirometry
KW - Tobacco Smoke Pollution/adverse effects
KW - GLOBAL BURDEN
KW - Health Economics
KW - Research bibliometrics
KW - SPIROMETRY
KW - PHARMACOLOGICAL-TREATMENT
KW - Health-Care burden
KW - Patients organizations
KW - ADJUSTED LIFE YEARS
KW - HEALTH
KW - LUNG-FUNCTION
KW - OF-LIFE
KW - PRIMARY-CARE
KW - BIOMASS SMOKE
KW - Chronic Obstructive Pulmonary Disease
KW - Psychological impact
KW - GENDER-DIFFERENCES
KW - COPD
UR - http://www.scopus.com/inward/record.url?scp=85078395826&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/8215126d-fbe4-3153-b979-786514ba4bb5/
U2 - 10.37201/req/2064.2019
DO - 10.37201/req/2064.2019
M3 - Article
C2 - 31933347
AN - SCOPUS:85078395826
VL - 33
SP - 49
EP - 67
JO - Revista Espanola de Quimioterapia
JF - Revista Espanola de Quimioterapia
SN - 0214-3429
IS - 1
ER -